Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0095 EUR | 0.00% | 0.00% | -5.00% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.89M 4.54M |
---|---|---|---|---|---|
Net income 2021 | -5M -4.64M | Net income 2022 | -5M -4.64M | EV / Sales 2021 | - |
Net cash position 2021 | 6.59M 6.12M | Net cash position 2022 | 3.7M 3.44M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.23
x | P/E ratio 2022 |
-0.87
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.54% |
1 month | +58.33% | ||
3 months | +90.00% | ||
6 months | -5.00% | ||
Current year | -5.00% |
Date | Price | Change |
---|---|---|
24-06-07 | 0.0095 | 0.00% |
24-06-06 | 0.0095 | 0.00% |
24-06-05 | 0.0095 | 0.00% |
24-06-04 | 0.0095 | 0.00% |
24-06-03 | 0.0095 | 0.00% |
Real-time Irish S.E., June 07, 2024 at 11:55 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.00% | 838K | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- OVXA Stock